INSIGHTS ON UPSTREAM MANUFACTURING
-
![mammlian-cell-lines-GettyImages-1690936576]( "Mammalian Cell Line Development")
Mammalian Cell Line DevelopmentExplores how modern cell line engineering boosts speed, stability, and scalability across biologics, with practical insights to cut risk and improve readiness for downstream development.
-
![bio-manufacturing-GettyImages-2194012901]( "Systematic Strategy To Reduce The Cost Of Goods Sold")
Systematic Strategy To Reduce The Cost Of Goods SoldLearn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.
-
![WuXia293Stable]( "WuXia293Stable: Express What CHO Can't")
WuXia293Stable: Express What CHO Can'tDiscover a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.
-
![RoosterBio - RoosterHD]( "A Highly Productive, Chemically Defined Exosome Media System")
A Highly Productive, Chemically Defined Exosome Media SystemExplore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.
-
Where MSCs Go When Injected And Why It Matters3/24/2026
Understand why IV-delivered MSCs undergo rapid apoptosis in lung tissue while locally implanted cells survive as programmable therapeutic factories—and how this knowledge enables rational MSC engineering.
-
Flexible Therapeutic Development: Balancing Speed, Cost, and Process3/24/2026
Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.
-
Engineering The Next Wave Of CHO Performance3/24/2026
By combining improved productivity with speed and reliability, S-CHOice® 2G helps biopharmaceutical companies optimize their manufacturing strategies, reduce overall costs, and respond more effectively to market demands.
-
Biocapacitance Measurement: A PAT Tool For Biomass Measurement In An Upstream Process3/20/2026
Leverage process analytical technologies (PAT) to gain real-time insight into product quality, strengthen control strategies, and build more efficient, scalable manufacturing processes for future success.
UPSTREAM MANUFACTURING SOLUTIONS
-
![RoosterBio - RoosterVial]( "RoosterVial™-hDF-XF: Xeno-Free (XF) Human Dermal Fibroblasts")
Learn how xeno-free human dermal fibroblasts achieve over 1 billion cells in 10 days through optimized 2D and 3D expansion protocols designed for clinical-scale therapeutic manufacturing applications.
-
![RoosterBio]( "RoosterReplenish™ hMSC Bioreactor Feed")
A concentrated bioreactor feed, RoosterReplenish-MSC-XF & prcRoosterReplenish-MSC-CC enable a fed-batch process for scalable, translation-ready cGMP hMSC manufacturing.
-
![GettyImages-172670893-cell-bank-cyropreservation-liquid-nitrogen]( "BioRepository Services")
Reliable sample protection comes from secure facilities. Learn how multiple storage formats, split‑site options, and full audit trails help ensure biological materials remain ready for future use.
-
![GettyImages-1259302414 lab, research, culture]( "Empower Your Studies With Our Expertise")
Look at how optimized virus banking strengthens manufacturing by enhancing consistency, speeding characterization timelines, and aligning testing strategies with modern regulatory expectations.
-
![GettyImages-506999858-scientists-cell-culture-lab-development]( "Starting Point Of Every Success Story")
Reliable cell banks are essential for protecting research quality. See how expert support and structured processes help maintain cell line integrity, reduce risk, and strengthen development.
